Companies: 10,795·Total market cap: $144.5T
Biora Therapeutics, Inc.

Biora Therapeutics, Inc.

BIOROTCHealthcare
$0.22
+$0.00(+0.00%)
Market Cap$994994
P/E Ratio
52W High$0.3802
52W Low$0.15

Biora Therapeutics, Inc. (BIOR) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · BIOR · as of Sep 30, 2025

Ownership Breakdown

Institutions 0.13%
Insiders 44.35%
Public 55.51%

1

Institutional Holders

▲ 1 vs Q2

$1,323

Total Inst. Value

▲ $1,323 vs Q2

4.52M

Shares Outstanding

freeFloat 55.65%

6,012

13F Shares Held

▲ 6,012 vs Q2

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

BIOR largest shareholders · institutional ownership

Q3 2025 · SEC 13F

Showing top 1 holders

HolderShares% OwnedWeightValueReportedChange

BARCLAYS PLC

pharmaceutical preparations

6.0K16.46%

16.46%

$3.02MMar 19, 2026NEW

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q3 2025 vs prior quarter

Q3 2025

Net institutional sentimentBullish — more buying than selling

0

Increased

+0 shares

1

New Positions

first time holders

0

Decreased

−0 shares

0

Sold Out

fully exited

Net shares change (top 50)

+0

+0 / −0

Net new holders

+1

1 new / 0 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

BIOR insider trading · insider activity

Source: SEC Form 4

7

Buy transactions

8

Sell transactions

0.88

Buy/Sell ratio

$8M

Total disposed

Recent Insider Transactions

Showing 10 most recent · Common Stock only

No recent insider transactions reported.

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

Biora Therapeutics, Inc. (BIOR) is primarily owned by institutional investors, who hold approximately 0.1% of total shares outstanding. Company insiders own approximately 44.35%, while retail and public investors account for the remaining 55.51%.

The largest institutional shareholder of Biora Therapeutics, Inc. is BARCLAYS PLC, holding approximately 6,012 shares — equal to 16.46% of outstanding shares — as of September 30, 2025.

A total of 1 institutional investors currently hold BIOR stock, with a combined institutional value of approximately $1,323 as of the most recent 13F filing period.

Frequently asked questions

BIOR ownership

Biora Therapeutics, Inc. (BIOR) is primarily owned by institutional investors, who hold approximately 0.1% of shares. The largest shareholder is BARCLAYS PLC with a 16.46% stake. Company insiders hold 44.35%. Data sourced from SEC Form 13F as of September 30, 2025.

who owns BIOR stockBIOR ownership structureSEC Form 13F institutional holdingsBIOR float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of September 30, 2025